Results 11 to 20 of about 61,520,573 (172)

Incidence Rate of Otitis Externa Episodes in Atopic Dogs Is Reduced by a Therapeutic Diet in a 6-Month Randomised, Blinded, Controlled, Clinical Trial. [PDF]

open access: yesVet Dermatol
ABSTRACT Background Recurrent otitis externa (OE) episodes commonly affect dogs with canine atopic dermatitis (cAD) despite ongoing cAD treatment. Objective To determine if a therapeutic diet with active ingredients targeting the skin barrier and allergy pathways reduces the incidence rate of OE.
Watson A   +5 more
europepmc   +2 more sources

Efficacy of Der f 2/Zen 1-LAMP1 Plasmid-Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof-of-Concept Study. [PDF]

open access: yesVet Dermatol
Background: DNA‐based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal‐associated membrane protein‐1 (LAMP). Objectives: This proof‐of‐concept study evaluated the efficacy and safety of a Der f 2/Zen 1‐LAMP‐based DNA vaccine immunotherapy in client‐owned dogs with nonseasonal AD ...
Bizikova P   +6 more
europepmc   +2 more sources

ePoster. [PDF]

open access: yesEur J Neurol
European Journal of Neurology, Volume 33, Issue S1, June 2026.
europepmc   +2 more sources

A randomised, double‐blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO‐524 in dogs with atopic dermatitis

open access: yesVeterinary Dermatology, Volume 34, Issue 6, Page 523-531, December 2023., 2023
Background – Polyunsaturated fatty acids (PUFA) can be beneficial in the management of canine atopic dermatitis (cAD). A commercial product PCSO‐524 containing PUFA has demonstrated anti‐inflammatory effects in dogs. Hypothesis/Objectives – To evaluate the efficacy of PCSO‐524, in combination with oclacitinib in dogs with cAD.
Takeo Nishiyama   +7 more
wiley   +1 more source

Measuring climate change adaptation policy output: Toward a two‐dimensional approach

open access: yesReview of Policy Research, Volume 40, Issue 6, Page 1058-1092, November 2023., 2023
Abstract As jurisdictions across the globe step up their efforts to adapt to climate change, it is important to assess progress by taking stock of and comparing adaptation policy. However, scholars and practitioners are struggling to conceptualize and measure adaptation policy.
Kai Schulze, Jonas J. Schoenefeld
wiley   +1 more source

Índice Acumulado [PDF]

open access: yes, 2022
Índice de autores y ...
Índice
core  

ÍNDICE

open access: yes, 2014
ÍNDICE\ua0PRELIMINARESEDITORIAL\ua0ARTÍCULOSRELACIONES ENTRE EL PODER EJECUTIVO Y EL LEGISLATIVOMireille Roccatti\ua0LOS MOTIVOS DE LA APERTURA A LA INVERSIÓN EXTRANJERA EN EL SECTOR FINANCIERO MEXICANO.Lucía Corona Arias\ua0ELEMENTOS DE ESTUDIO DEL ...
DED, Índice; Correctora de estilo
core   +2 more sources

Índice de Autores y Materias

open access: yes, 2021
Índice de autores y ...
y Materias, Índice de Autores
core   +1 more source

Assessing habitat suitability for black grouse broods at the bioregional scale

open access: yesWildlife Biology, Volume 2026, Issue 4, July 2026.
The black grouse Lyrurus tetrix, a galliform species emblematic of the European Alps, is currently threatened by habitat change, particularly given the closure of heathland linked to the rising tree line at higher altitudes. The presence of heathlands in good ecological condition is, however, imperative for the species' reproduction.
Alexandre T. M. Defossez   +6 more
wiley   +1 more source

Company Websites: A New Measure of Disclosure

open access: yesJournal of Accounting Research, Volume 64, Issue 1, Page 81-125, March 2026.
Abstract We propose a new measure of firms' disclosure based on company websites, which are widely available and contain a wealth of information. For a sample of U.S. public firms, we construct our disclosure measure using historical website data, validate it by correlating it with extant measures of disclosure and information asymmetry, and explore ...
ROMAIN BOULLAND   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy